Les médicaments à base de plante

Abstract

In a context marked by growing demand for natural health products, phytomedicines are gaining an increasingly important place in contemporary therapeutic practices. Their plantbased origin, accessibility, and generally perceived better tolerance make them viable alternatives to conventional treatments. In Algeria, their use is expanding significantly, although their regulatory framework remains insufficiently structured. The national market suffers from a lack of clear legislation, limited product standardization, and a shortage of reliable data, raising concerns about their quality, safety, and efficacy. Moreover, the ambiguous coexistence between phytomedicines and dietary supplements complicates their classification and dispensing procedures. In this context, the present thesis undertakes a targeted descriptive survey among community pharmacists in the eastern region of Algeria, specifically in the wilayas of Sétif and Bordj Bou Arreridj. Data were collected using a structured questionnaire and statistically analyzed, with the aim of providing an overview of the phytomedicines available, analyzing their uses, pharmaceutical forms, origins, regulatory status, and turnover rate. The survey highlights the significant growth of the Algerian phytomedicine market, characterized by their strong presence in pharmacies and the expansion of local production— reflecting a national ambition for pharmaceutical self-sufficiency. However, this dynamic is accompanied by persistent regulatory shortcomings, particularly regarding labeling and dispensing practices. Added to this is a clear disparity in reimbursement mechanisms, as most products remain uncovered. Furthermore, the product offering is primarily geared toward the treatment of respiratory and digestive disorders, reflecting a targeted response to the most common therapeutic needs.